• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume8, Issue2

STUDY OF LIPID STATUS IN PARKINSON’S DISEASE

    Dr.Meenal Vaidya,Dr. Vandana Varma,Dr. Sunil Singh Narwaria,Dr. Vibha Khare,Dr. Purnima Dey Sarkar, Dr Shiv Narayan Lehariya

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 2, Pages 2787-2791

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background &Method: The aim of the study is to determine lipid status in one of the common neurodegenerative disease i.e Parkinson’s disease patients. 5 ml fasting blood samples from patients sex & age matched controls were collected from antecubital vein, with all aseptic precaution in plain vacutainers.
 
Result: Serum total cholesterol level and LDL cholesterol was significantly low in Parkinson’s patients as compared with control group. Serum HDL cholesterol level was slightly low, but not significantly different as compared with controls.
 
Conclusion: Finally from our work we observed that Serum Total cholesterol and Serum LDL cholesterol levels are significantly decreased, in Parkinson’s disease patients as compared with controls. Serum HDL cholesterol is slightly decreased & did not show any statistical difference in Parkinson’s disease patients as compared with healthy controls suggesting dysregulation of lipid metabolism in PD patients.
Keywords:
    lipids Parkinson’s disease HDL LDL
  • PDF (244 K)
  • XML
(2022). STUDY OF LIPID STATUS IN PARKINSON’S DISEASE. European Journal of Molecular & Clinical Medicine, 8(2), 2787-2791.
Dr.Meenal Vaidya,Dr. Vandana Varma,Dr. Sunil Singh Narwaria,Dr. Vibha Khare,Dr. Purnima Dey Sarkar, Dr Shiv Narayan Lehariya. "STUDY OF LIPID STATUS IN PARKINSON’S DISEASE". European Journal of Molecular & Clinical Medicine, 8, 2, 2022, 2787-2791.
(2022). 'STUDY OF LIPID STATUS IN PARKINSON’S DISEASE', European Journal of Molecular & Clinical Medicine, 8(2), pp. 2787-2791.
STUDY OF LIPID STATUS IN PARKINSON’S DISEASE. European Journal of Molecular & Clinical Medicine, 2022; 8(2): 2787-2791.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 60
  • PDF Download: 33
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus